The role of complement in inflammation and adaptive immunity

Immunological Reviews

Volumn 180, Issue , 2001, Pages 5-15

  Barrington, Robert ^a   Zhang, Ming ^a   Fischer, Michael ^b   Carroll, Michael C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; BACTERIAL INFECTION; COMPLEMENT SYSTEM; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION PREVENTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CHIMERA; COMPLEMENT C3; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; DNA-BINDING PROTEINS; DOGS; GENE TARGETING; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; INFLAMMATION; MAST CELLS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NUCLEAR PROTEINS; PERITONITIS; RECEPTORS, COMPLEMENT; REPERFUSION INJURY;

EID: 0035008464     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1800101.x     Document Type: Review

References (43)

1. 1. Hourcade D, Holers VM, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989;45:381-416.
2. 2. Xu C, Mao D, Hoilers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 2000;287:498-501.
3. 3. Weisman HF, et al. Soluble human complement receptor type I: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-151.
4. 4. Weiser M, et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996;183:2343-2348.
5. 5. Shinkai Y, et al. Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-867.
6. 6. Williams JP, et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999;86:938-942.
7. + B cells. Immunol Rev 1994;137:91-118.
8. 8. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
9. 9. Prodeus A, Zhou X, Maurer M, Galli S, Carroll MC. Impaired mast cell-dependent natural immunity to acute septic peritonitis in C3 deficient mice. Nature 1997;390:172-175.
10. 10. Boes M, Prodeus A, Schmidt T, Carroll MC, Chen J. A critical role of natural IgM in immediate response against systemic bacterial infection. J Exp Med 1998;188:2381-2386.
11. 11. Gommerman JL, et al. A role for CD21/ CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol 2000;165:6915-6921.
12. 12. Lay WH, Nussenzweig V. Receptors for complement on leukocytes. J Exp Med 1968;128:991-1009.
13. 13. Pepys MB. Role of complement in induction of the allergic response. Nat New Biol 1972;237:157-159.
14. 14. Papamichail M, Gutierrez C, Embling P, Johnson P, Holborow EJ, Pepys MB. Complement dependence of localization of aggregated IgG in germinal centers. Scand J Immunol 1975;4:343-345.
15. 15. Jackson CG, Ochs HD, Wedgewood RJ. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 1979;300:1124-1129.
16. 16. Ochs HD, Wedgwood RJ, Frank MM, Heller SR, Hosea SW. The role of complement in the induction of antibody responses. Clin Exp Immunol 1983;53:208-216.
17. 17. Bottger EC, Metzger S, Bitter-Suermann D, Stevenson G, Kleindienst S, Burger R. Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol 1986;16:1231-1235.
18. 18. O'Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA. Role of C3 in humoral immunity: defective antibody production in C3-deficient dogs. J Immunol 1988;140:1939-1945.
19. 19. Bottger EC, Hoffmann T, Hadding U, Bitter-Suermann D. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol 1985;135:4100-4107.
20. 20. Fischer M, et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 1996;157:549-556.
21. 21. Law SK, Lichtenberg NA, Levine RP. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci USA 1980;77:7194-7198.
22. 22. Melchers F, Erdei A, Schulz T, Dierich MP. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 1985;317:264-267.
23. 23. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TT, Fearon DT. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J Exp Med 1991;173:55-64.
24. 24. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TT. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferate antibody-1 and Leu-13 molecules. J Immunol 1992;149:2841-2850.
25. 25. Carter RH, Fearon DT, CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992;256:105-107.
26. 26. Heyman B, Wiersma EJ, Kinoshita T. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J Exp Med 1990;172:665-668.
27. 27. Typhronitis G, et al. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 1991;147:224-230.
28. 28. Hebell T, Ahearn JM, Fearon DT. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991;254:102-105.
29. 29. Kurtz CB, O'Toole E, Christensen SM, Weis JH. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 1990;144:3581-3591.
30. 30. Molina H, Kinoshita T, Inoue K, Carel J-C, Holers VM. A molecular and immunochemical characterization of mouse CR2. J Immunol 1990;145:2974-2983.
31. 31. Ahearn J, et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996;4:251-262.
32. 32. Molina H, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996;93:3357-3361.
33. 33. Croix D, et al. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 1996;183:1857-1864.
34. 34. Shokat K, Goodnow C. Antigen-induced B-cell death and elimination during germinal centre immune response. Nature 1995;375:334-338.
35. 35. Fischer MB, et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 1998;280:582-585.
36. + T cells. Nature 1995;376:181-184.
37. 37. Liu YJ, Arpin C. Germinal center development. Immunol Rev 1997;156:111-126.
38. 38. MacLennan I. Germinal centers. Annu Rev Immunol 1994;12:117-139.
39. 39. Arvieux J, Yssel H, Colomb M. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 1988;65:229-235.
40. 40. Jacquier M, Gabert F, Villiers M, Colomb M. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995;84:164-170.
41. 41. O'Rourke L, et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998;8:635-645.
42. -/- mice is rescued by adjuvants without improvement in germinal center development. J Immunol 2001;165:3119-3127.
43. 43. Reid RR, et al. The role of complement receptors CD21/CD35 in positive selection of B-1 cells. Curr Top Microbiol Immunol 1999;252:57-65.